- Anxiety
- Depression
- Alzheimer's Disease
- Weight Loss
- Heart Disease
- Cancer
- Asthma
Trial Phase
Trial Status
Paid Participation
21 Mycosis Fungoidessezary Syndrome Trials Near You
Power is an online platform that helps thousands of Mycosis Fungoidessezary Syndrome patients discover FDA-reviewed trials every day. Every trial we feature meets safety and ethical standards, giving patients an easy way to discover promising new treatments in the research stage.
Learn More About PowerHyBryte Cream for Cutaneous T-Cell Lymphoma
Trial Details
Key Eligibility Criteria
80 Participants Needed
Fenretinide for T-Cell Lymphoma
Trial Details
Key Eligibility Criteria
46 Participants Needed
IPH4102 for Cutaneous T-Cell Lymphoma
Trial Details
Key Eligibility Criteria
170 Participants Needed
FLT PET Imaging for Cancer
Trial Details
Key Eligibility Criteria
80 Participants Needed
Imiquimod + Radiation Therapy for Mycosis Fungoides
Trial Details
Key Eligibility Criteria
25 Participants Needed
CAR-T Cell Therapy for Lymphoma
Trial Details
Key Eligibility Criteria
59 Participants Needed
Tulmimetostat for Skin Cancer
Trial Details
Key Eligibility Criteria
36 Participants Needed
Hypericin Ointment + Visible Light for Mycosis Fungoides
Trial Details
Key Eligibility Criteria
20 Participants Needed
Pembrolizumab + Gemcitabine for Cutaneous T-Cell Lymphoma
Trial Details
Key Eligibility Criteria
28 Participants Needed
Brentuximab Vedotin for Cutaneous T-Cell Lymphoma
Trial Details
Key Eligibility Criteria
58 Participants Needed
Ritlecitinib for Cutaneous T-Cell Lymphoma
Trial Details
Key Eligibility Criteria
7 Participants Needed
Photopheresis for Mycosis Fungoides
Trial Details
Key Eligibility Criteria
74 Participants Needed
Mogamulizumab + Brentuximab Vedotin for Mycosis Fungoides
Trial Details
Key Eligibility Criteria
10 Participants Needed
Mogamulizumab + DA-EPOCH for T-Cell Lymphoma
Trial Details
Key Eligibility Criteria
22 Participants Needed
Modified Virus and Immunotherapy for T-Cell Lymphoma
Trial Details
Key Eligibility Criteria
20 Participants Needed
Phototherapy + Mogamulizumab for Mycosis Fungoides
Trial Details
Key Eligibility Criteria
20 Participants Needed
SGN-35 for Skin Lymphomas
Trial Details
Key Eligibility Criteria
79 Participants Needed
Trial Details
Key Eligibility Criteria
30 Participants Needed
Low-Dose Radiation Therapy for Mycosis Fungoides
Trial Details
Key Eligibility Criteria
50 Participants Needed
Cemiplimab for Cutaneous T-Cell Lymphoma
Trial Details
Key Eligibility Criteria
Why Other Patients Applied
"As a healthy volunteer, I like to participate in as many trials as I'm able to. It's a good way to help research and earn money."
"I was diagnosed with stage 4 pancreatic cancer three months ago, metastatic to my liver, and I have been receiving and responding well to chemotherapy. My blood work revealed that my tumor markers have gone from 2600 in the beginning to 173 as of now, even with the delay in treatment, they are not going up. CT Scans reveal they have been shrinking as well. However, chemo is seriously deteriorating my body. I have 4 more treatments to go in this 12 treatment cycle. I am just interested in learning about my other options, if any are available to me."
"I've tried several different SSRIs over the past 23 years with no luck. Some of these new treatments seem interesting... haven't tried anything like them before. I really hope that one could work."
"I changed my diet in 2020 and I’ve lost 95 pounds from my highest weight (283). I am 5’3”, female, and now 188. I still have a 33 BMI. I've been doing research on alternative approaches to continue my progress, which brought me here to consider clinical trials."
"My orthopedist recommended a half replacement of my right knee. I have had both hips replaced. Currently have arthritis in knee, shoulder, and thumb. I want to avoid surgery, and I'm open-minded about trying a trial before using surgery as a last resort."
Mogamulizumab + LD TSEBT for Cutaneous Lymphoma
Trial Details
Key Eligibility Criteria
30 Participants Needed
Know someone looking for new options?
Spread the word
Learn More About Power
We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.
Frequently Asked Questions
How much do Mycosis Fungoidessezary Syndrome clinical trials pay?
Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range for Phase 2–4 trials (Phase 1 trials often pay substantially more). Further, most trials will cover the costs of a travel to-and-from the clinic.
How do Mycosis Fungoidessezary Syndrome clinical trials work?
After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll be sorted into one of the treatment groups, and receive your study drug. For some trials, there is a chance you'll receive a placebo. Across Mycosis Fungoidessezary Syndrome trials 30% of clinical trials have a placebo. Typically, you'll be required to check-in with the clinic every month or so. The average trial length for Mycosis Fungoidessezary Syndrome is 12 months.
How do I participate in a study as a "healthy volunteer"?
Not all studies recruit healthy volunteers: usually, Phase 1 studies do. Participating as a healthy volunteer means you will go to a research facility several times over a few days or weeks to receive a dose of either the test treatment or a "placebo," which is a harmless substance that helps researchers compare results. You will have routine tests during these visits, and you'll be compensated for your time and travel, with the number of appointments and details varying by study.
What does the "phase" of a clinical trial mean?
The phase of a trial reveals what stage the drug is in to get approval for a specific condition. Phase 1 trials are the trials to collect safety data in humans. Phase 2 trials are those where the drug has some data showing safety in humans, but where further human data is needed on drug effectiveness. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. As a general rule, Phase 3 trials are more promising than Phase 2, and Phase 2 trials are more promising than phase 1.
Do I need to be insured to participate in a Mycosis Fungoidessezary Syndrome medical study?
Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.
What are the newest Mycosis Fungoidessezary Syndrome clinical trials?
Most recently, we added HyBryte Cream for Cutaneous T-Cell Lymphoma, Cemiplimab for Cutaneous T-Cell Lymphoma and Mogamulizumab + DA-EPOCH for T-Cell Lymphoma to the Power online platform.